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Selective Cryolysis of Sebaceous Glands
H. Ray Jalian1,2,6, Joshua Tam2,3,6, Linh N. Vuong2, Jeremy Fisher2, Lilit Garibyan2,3, Martin C. Mihm4,
David Zurakowski5, Conor L. Evans2,3 and R. Rox Anderson2,3
Acne vulgaris is a nearly universal cutaneous inﬂammatory disease. Excess sebum production is an integral part
of disease pathogenesis. Medical therapies that reduce sebum excretion result in clinical improvement of acne.
Given the preferential susceptibility of lipid-containing cells to cold, we investigated the hypothesis that
controlled local skin cooling causes preferential injury to sebaceous glands, in murine and swine models using a
range of temperatures as low as − 10 °C, and then on the backs of human subjects. In mouse ears, peak histologic
damage occurred 72 hours after treatment; eosinophilic necrotic plugs formed within sebaceous glands, and the
number of glands was signiﬁcantly reduced up to 1 week post treatment. Cooling disrupted sebocyte cell
membranes, alkaline phosphatase activity, and signiﬁcantly reduced sebocyte lipid content. In human
volunteers, cooling damaged sebaceous glands and reduced sebum output for 2 weeks, with minimal injury
to surrounding tissues. Selective cryolysis of sebaceous glands is achievable through brief, non-invasive skin
cooling, suggesting that controlled cooling could be developed as an effective treatment for acne vulgaris.
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INTRODUCTION
Acne vulgaris affects 80–95% of adolescents and often
persists into adulthood. The pathogenesis is multifactorial,
involving aberrant follicular keratinization, increased sebum
excretion, proliferation of Propionibacterium acnes, and
inﬂammation (Knutsen-Larson et al., 2012; Zaenglein and
Thiboutot, 2012). Many current therapies for acne—including
isotretinoin (Nelson et al., 2008), anti-androgens (Katsambas
and Dessinioti, 2010), and photodynamic therapy (Sakamoto
et al., 2010)—reduce acne, at least in part, by damaging
sebaceous glands and/or decreasing sebum excretion, and a
30–50% sebum reduction is correlated with improvements in
clinical acne measures (Janiczek-Dolphin et al., 2010).
However, most current therapies are associated with signiﬁ-
cant side effects (Tripathi et al., 2013); therefore, alternative
methods of attenuating sebaceous glands are desirable.
Cryotherapy has a long history in dermatology. Solid
carbon dioxide (−78 °C) and liquid nitrogen (−195 °C) have
been used for decades for the nonspeciﬁc destruction of
epidermal lesions such as actinic keratosis or verruca vulgaris
(Cooper and Dawber, 2001). Our laboratory previously found
that localized cooling can be used to selectively remove fat
tissue, with minimal injury to surrounding tissues. The
putative mechanism involves crystallization of cytoplasmic
lipids at temperatures higher than the freezing point of tissue
water (Manstein et al., 2008). This noninvasive technology,
called cryolipolysis, is now widely used for local reduction of
unwanted subcutaneous fat. As sebaceous glands have high
(~30%) lipid contents (Sakamoto et al., 2012), we reasoned
that they may also be preferentially susceptible to cold injury.
Sebaceous gland damage in animals after localized cryoinjury
was ﬁrst reported decades ago (Gage et al., 1979), but the
potential and conditions for selective effect on sebaceous
glands are unknown. We conducted the current study to
establish the feasibility of selectively damaging sebaceous
glands by localized skin cooling, ﬁrst in animal models and
then in a pilot clinical trial with human volunteers.
RESULTS
Murine model
By varying cooling parameters such as temperature, exposure
time, cooling rate, and the number of cooling cycles (Table 1),
we identiﬁed conditions at which sebaceous glands were
selectively damaged, with little to no injury of surrounding
tissues. One such combination—cooling at a device tem-
perature of − 7 °C for 10 minutes—was explored more
extensively and is presented below.
In the days following the cooling procedure, sebaceous
glands in the treated regions exhibited a progressive loss of
cellular structures, including intracellular lipid granules, nuclei,
sebocyte membranes, and intercellular septa, concurrent with
the accumulation of an eosinophilic precipitate (Figure 1a).
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These histologic signs of cellular damage were maximal on
the 3rd post-treatment day, present in over 60% of the glands.
In contrast, o5% of the glands in untreated control mouse
ears showed any histologic evidence of damage. The treated
glands gradually recovered their normal morphology, and by
1 week o10% of the glands remained damaged (Figure 1b).
There was transient swelling in the ear after cooling, but
otherwise no gross or histologic evidence of nonspeciﬁc
damage to surrounding skin or cartilage tissues was observed.
Of note, there was a small but signiﬁcant (Po0.001)
reduction in the absolute number of glands in the treated
samples, which persisted after 1 week, despite nearly
complete recovery of the histological features in the remain-
ing glands, suggesting that some glands may have been
irreversibly damaged by cooling (Figure 1c).
Propidium iodide (PI), a membrane-impermeable dye, was
used to label cells with compromised membranes. PI staining
was minimal in untreated controls—most glands showed no
staining, whereas a small number of glands had positive
staining in the area immediately adjacent to the hair follicle
(Figure 2a and c), consistent with the normal degeneration of
secreted sebocytes. In contrast, post-cooling glands showed
extensive PI staining throughout the glands, co-localized with
both the nuclei and lipids in the glands (Figure 2b and d).
Alkaline phosphatase (ALP) activity, normally prominent in
sebaceous glands (Figure 2e), was substantially diminished
(Figure 2f) at the time point corresponding to maximal
histologic damage (3 days post cooling). At the same 3-day
time point, cooling did not disrupt the expression of key
protein markers associated with sebaceous glands (Figure 2i),
including Keratins 5 and 15, Ki67, MUC1 (Mucin 1, Cell
Surface Associated), MC5R (melanocortin receptor-5), and
PPARγ (Peroxisome proliferator–activated receptor gamma).
However, lipid contents in the treated glands were substan-
tially reduced and in some cases completely abolished
(Figure 2h).
Table 1. Cooling parameters for selective cryolysis of sebaceous glands in murine model
Experimental group Constant Variable
1 Duration=10min
maximal cooling rate
Temperature
0 °C −5 °C − 7 °C −10 °C
− ± + + SG
− − − + NS
2 Temperature=−7 °C
maximal cooling rate
Duration
0min 5min 10min 15min
− − + + SG
− − − − NS
3 Temperature=−7 °C
duration=10min
Rate
Cooling rate1
Max 2min Max 2min
Thawing rate2
Ambient Ambient 2 min 2min
+ − + − SG
− − + − NS
4 Temperature=−7 °C Freeze-thaw cycles
One 10-min cycle Two 10-min cycles Two 5-min cycles Five 2-min cycles
+ + + + SG
− + + + NS
Abbreviations: NS, non-speciﬁc injury; SG, sebaceous gland injury. +, = histologic signs of injury. − , no sign of injury.
Different cooling parameters were explored in four experimental groups: (1) The cold plate was cooled to different target temperatures, whereas cooling
duration was held constant and maximal cooling rate (i.e., cold plate was pre-cooled to target temperature prior to beginning treatment) was used; (2)
Different treatment durations were used, at constant target temperature and cooling rate; (3) Different cooling and thawing rates were used, at constant target
temperature and duration; and (4) Different numbers of cooling cycles were used, with thawing between each cycle, and the target temperature held constant.
Selective damage to sebaceous glands, with minimal non-speciﬁc damage to surrounding tissues, was achieved under certain cooling parameters, as shown
in this table.
1Max cooling rate denotes that the cold plate was pre-cooled to target temperature prior to contact with tissue. For a 2 min cooling rate, the cold plate was
initially heated to 37 °C and then after contact with the tissue gradually cooled to target temperature over 2 min.
2
“Ambient” thawing rate denotes that the tissue was exposed to room temperature (~25 °C) immediately after cooling treatment. For a 2min thawing rate, after
cooling treatment the cold plate was gradually heated to 37 °C over 2 min, and then the treated tissue was removed.
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Porcine model
We performed a similar cooling procedure in the porcine ear
model, which is anatomically similar to human sebaceous
skin (Sakamoto et al., 2009). Sebaceous glands in porcine ears
were also damaged by cooling, with minimal nonspeciﬁc
injury to surrounding tissues (Supplementary Figure S2
online).
Human study
A pilot clinical trial was conducted in 11 healthy male
volunteers with measurable sebum output. Fair-skinned
subjects of Fitzpatrick skin phototypes I–III were enrolled to
limit the potential risk of cold-induced hypopigmentation,
which was not observed in any subject. Subjects were
randomized to one of the two cooling device target
temperatures (−10 or − 15 °C). Two treatment areas of their
backs were cooled either for a single 20 minute cycle or two
10-minute cycles with re-warming in between. Each subject
also had one untreated area in the same anatomic region to
serve as control. Biopsies taken 72 hours after treatment
showed obvious yet selective damage in sebaceous glands,
with necrosis and architectural distortion of lipid-laden
sebocytes within the sebaceous gland (Figure 3). No
histologic evidence of non-selective tissue damage was
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Figure 1. Cooling damaged sebaceous glands in mice. (a) Gross and histologic appearance of murine ears at various time points following cooling at − 7 °C for
10 minutes. Note the retraction of lipid laden sebocytes from peripheral cells at day 2. By day 3, there was an eosinophilic plug within gland lumens. By day 5
glands exhibited normal architecture, and lipid accumulation appeared to be at baseline by day 7. The gross appearance of the ear remained normal at all time
points. (b) Damaged glands as a percentage of total glands, mean± SEM. Gland damage (deﬁned as three or more necrotic cells present within a sebaceous gland)
was substantially increased after cooling to –7 °C for 10 minutes. (c) Total number of glands (shown as number of glands per each cross section of the ear) was
decreased at 72 hours and 1 week following treatment. Glands from three different animals treated with the same conditions were evaluated at each time point for
(b and c). * denotes signiﬁcant difference (Po0.001) compared with control group.
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observed. Similar to our murine results, expression of the
proliferative marker Ki67 and the progenitor basal cell marker
keratin 15 was not disrupted by cooling, as determined by
immunohistochemistry (Supplementary Figure S3 online),
which is consistent with the ability of sebaceous glands
to eventually recover after treatment. Sebum production
decreased signiﬁcantly compared with baseline at 1 and
2 weeks after treatment and then recovered to baseline levels
by week 4 (Figure 4). There were no signiﬁcant changes in
sebum production in untreated control sites compared with
baseline, over the 4-week course of the study. There were no
signiﬁcant differences in any of the measured outcomes
between the different treatment temperatures and cycles. The
treatment was very well tolerated. There was localized, mild,
transient erythema, edema, and dysesthesia after cooling, all
of which resolved spontaneously within 72 hours (Figure 5).
During treatment, the subjects reported an average score of 3
on a 10-point Visual Analog Scale for pain, which fell to o1
immediately post treatment and was 0 by 72 hours.
DISCUSSION
In this study, we showed that sebaceous glands can be
preferentially damaged by controlled cooling at the skin
surface, with minimal (in mice) to no (in humans) nonspeciﬁc
injury to surrounding tissues under the conditions we studied.
Cooling temporarily disrupted cellular architecture, mem-
brane integrity, enzymatic activity, and reduced lipid content
in sebaceous glands. In humans, cooling to −10 or − 15 °C
for 20 minutes resulted in an approximate 20% suppression of
sebum output that persisted for over 2 weeks.
Our murine experiments illustrate the relative importance
of the cooling parameters of temperature, rate of cooling, and
duration of cold exposure. The most important factors to
achieve consistent and selective damage to sebaceous glands
in mice were the rate of cooling and the target temperature.
Regardless of target temperature, selective damage to sebac-
eous glands was not evident at slow cooling rates. Interest-
ingly, the temperatures needed to damage sebaceous glands
were far lower compared with the temperature for the onset of
lipid crystallization of sebum, which in humans is reportedly
about 15 °C (Burton, 1970). The need for sub-zero tempera-
tures suggests that a “water-freeze”, in addition to the “lipid-
freeze”, may be necessary for the histologic end point. We
hypothesize that the relatively low water content of sebocytes
may predispose these and similar cells to lethal injury by
combined lipid and water crystallization. Classically, freezing
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Figure 2. Cooling disrupted cell membranes and enzymatic activity and reduced lipid content of sebocytes. (a–d) Propidium iodide (PI) staining in sebaceous
glands from treated ears (b and d) and contralateral controls (a and c), 2 hours after treatment. Lipids were stained by BODIPY lipid dye and shown in green. Nuclei
were labeled by Hoechst stain, shown in blue. PI staining is shown in red. (c) and (d) show PI staining—only for the same glands shown in (a) and (b), respectively. PI
staining was minimal in untreated controls and when present was restricted to the region immediately adjacent to the hair follicle (a and c). Treated glands showed
extensive PI staining, which co-localized with both nuclei and sebum lipids (b and d). (e and f) Alkaline phosphatase was highly active (shown in red) in untreated
glands (e) but was substantially diminished in treated glands 3 days after cooling (f). (g–i) Lipid content in sebaceous glands is reduced by cooling. Representative
z-projection images from four different animals are shown. (g and h) Keratin 5 (red), lipids (green), and nuclei (blue) were labeled by whole-mount staining, as
described in the text. (g): Untreated sebaceous glands (arrows) showing expected morphology: basal epithelium expressing keratin 5 and lipid-ﬁlled gland interior.
(h) Three days after cooling, keratin 5 expression was retained in the treated glands, but lipid content was substantially reduced and in some cases almost completely
abolished (arrow). (i) High-power view of various protein markers in sebaceous glands labeled by whole-mount staining, shown in red. Lipids shown in green, nuclei
in blue. Cooling did not disrupt the expression of any of these markers, but lipid content was diminished. Scale bars= (a–f and i) 25 μm, (g and h) 100 μm.
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injury to cells can be greater at rapid cooling rates (Gao and
Critser, 2000), as was also observed in our study of cold-
induced sebocyte injury. The remainder of the variables we
explored were concordant with the current cryobiology
Figure 3. Cooling disrupts cellular architecture in human sebaceous glands.
(a) Sebaceous gland from untreated area, showing normal sebaceous gland
architecture: lipid-laden sebocytes ﬁlling the gland interior, and sebocytes
nearest the gland duct—which are about to undergo cell lysis as part of the
holocrine secretion process—containing increased lipid content and pyknotic
nuclei. (b) Three days after cooling at −10 °C for 20 minutes, degenerative
changes are seen in the sebaceous glands, including loss of intracellular lipid
granules, pyknotic nuclei throughout the gland body, and the presence of an
eosinophilic precipitate. Scale bars=50 μm.
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Figure 4. Cooling suppresses sebum output in humans. Sebum output was
measured at various time points using a Sebumeter. Data from the − 15 and
− 10 °C groups were combined, as there was no statistical difference between
the two groups. Following cooling treatment of either one 20 minute cycle
(Treatment A) or two 10-minute cycles (Treatment B), sebum output was
signiﬁcantly lower than baseline at 1 (Po0.002) and 2 (Po0.0005) weeks post
treatment. In contrast, there was no signiﬁcant difference in sebum output from
untreated sites (Control) across the different time points. Data shown as
means±95% conﬁdence intervals in Sebumeter units. * denotes signiﬁcant
difference between post-treatment and baseline sebum output. AU,
arbitrary units.
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literature: increasing numbers of freeze-thaw cycles or slower
thawing were both more destructive and resulted in non-
speciﬁc tissue injury.
The extensive staining by PI, a membrane-impermeable
dye, in sebaceous glands shortly (within hours) after treatment
indicates that the sebocytes’ cell membranes were compro-
mised by cooling. PI staining was minimal in untreated
controls and when present was restricted to the area
immediately adjacent to the hair follicle, which corresponds
to the location where mature sebocytes normally undergo cell
death and release their lipid contents as part of the holocrine
secretion mechanism. Sebaceous glands normally have a high
level of endogenous ALP activity (Handjiski et al., 1994).
This activity was substantially diminished 3 days after
cooling, indicating that the treatment had at least temporarily
disrupted some enzymatic machinery of the sebaceous glands.
Interestingly, ALP activity remained high in untreated glands,
even after prolonged storage at − 80 °C, which suggests that
the post-treatment reduction in ALP activity was not merely a
consequence of exposure to low temperatures but rather a
cellular response to the cooling treatment. Further studies are
required to determine the exact nature of this response. Lipid
content was also reduced in the treated glands, which is
consistent with our observation in a previous imaging study
(Jung et al., 2015) and also with the reduced post-treatment
sebum output seen in our clinical trial (Figure 4).
The pilot clinical trial showed the feasibility of selectively
damaging human sebaceous glands with controlled cooling,
at parameters that were safe and easily tolerated by
all 11 subjects in the study. The reduced sebum excretion
following a single application of cooling in healthy
human subjects strongly suggests that the histologic damage
observed correlates with decreased sebum output. Previous
studies have shown that prolonged reduction in sebum is
correlated with improvement in clinical outcome measures
(Janiczek-Dolphin et al., 2010).
The severity of cooling-induced injury to sebaceous glands
achieved in our study appears to be temporary. Cooling in the
mouse ear did not disrupt the expression of key protein
markers in the treated glands, and, although the quantitative
analysis of gland density suggests some degree of long-term
attenuation, most of the glands showed histologic recovery
within 1 week. In the porcine ear, histologic features and
density of sebaceous glands both recovered within 4 weeks
after treatment. Sebum output also recovered by 4 weeks after
treatment in human subjects. Although it is possible that
treatment parameters could be further optimized to prolong
the injurious effects on sebaceous glands, the relatively short
duration of damage does not necessarily preclude controlled
cooling as a treatment for acne: photodynamic therapy has
been reported to have a similar time course (~10 days) for
post-treatment recovery of sebaceous glands (Divaris et al.,
1990); yet, photodynamic therapy has proven to be an
effective therapy for acne (Sakamoto et al., 2010). In addition,
as the complete absence of sebum could potentially have
undesirable effects on skin health, the temporary suppression
of sebum output may be preferable to permanently destroying
sebaceous glands. The sebum reduction in our human study
lasted for at least 2 weeks following a single cooling
treatment. These results suggest, but do not verify, that a
treatment interval of about 2 weeks may be able to provide
prolonged suppression of sebaceous gland activity. We did
not study the effects of a series of cooling treatments. On one
hand, sebaceous glands may potentially exhibit cumulative
selective damage; on the other hand, there may be
mechanisms for adaptation of the glands to repeated cold
injury. Further investigation is warranted in order to determine
response of acne vulgaris to controlled cooling and to
optimize treatment parameters.
Historically, the use of cryotherapy to treat acne has
signiﬁcant clinical support. Original reports using carbon
dioxide slurry for this purpose date back to the early 20th
century (Giraudeau, 1928). Larger scale, more rigorous
studies from the 1940s to the 1950s emphasized the use of
cryotherapy for the treatment of acne and acne-related
scarring (Dobes, 1951). This technique was later abandoned
for various reasons including the risk of cryogen-induced
ulcers or hypopigmentation, technical difﬁculty, the incon-
venience of storing dry ice and preparing the slurry, and the
emergence of drug therapies. Despite the passage of nearly a
Pre-treatment
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Figure 5. Clinical photos from a representative subject taken before and up
to 4 weeks after cooling treatment. This particular subject was randomized to
−15 °C treatment. The left lateral site was the untreated control, left paraspinal
site was treated with two separate 10-minute cycles, and the right paraspinal
site was treated with one continuous 20-minute cooling cycle. Photos were
taken before (a), immediately after (b), and at 3 days (c), 1 week (d), 2 weeks
(e), and 4 weeks (f) after cooling treatment. Panel (b) consists of two photos
taken after a 20-minute cycle (b, left) and two 10-minute cycles (b, right),
respectively. There was mild inﬂammation and local dysesthesia that
spontaneously resolved within days.
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century from the original description of cryotherapy for acne,
we ﬁnd ourselves ironically in a similar clinical predicament.
In the early 20th century, the most effective acne treatment
was ionizing radiation, which was later abandoned because
of side effects. Currently, oral isotretinoin is by far the most
efﬁcacious option for treating acne, but the drug is mired in
controversy relating to its teratogenecity, controversial suicid-
ality, and inﬂammatory bowel disease risks (Prevost and
English, 2013). Antibiotic therapy is also problematic, as
prolonged usage increases the risk of fostering antibiotic-
resistant bacterial strains (Tzellos et al., 2011). Furthermore,
large advances in controlled skin cooling technology have
occurred as the bygone heyday of acne cryotherapy. With the
ability to separately control cooling rate, skin temperature,
timing, number of cooling cycles, and the detection of freeze
events within the tissue, devices could be made that provide
far more precision and safety features than conventional dry
ice or liquid nitrogen cryotherapy. Potentially, such devices
could be used in dermatology practices or, if sufﬁciently safe
for consumer use, at home. Although the ﬁnding in this study
of transient damage to sebaceous glands and reduction in
sebum output is promising, this was an investigation of
normal skin response and not an acne treatment study. The
morphology and function of sebaceous glands, as well as
sebum composition, are all altered in acne. It is possible that
the effects of cooling are different in sebaceous glands
affected by acne, compared with “normal” glands. In
addition, acne is a multifactorial disease, and other factors,
such as the accumulation of P. acnes and local inﬂammation,
are thought to have important roles. How cooling affects all
these other factors is also not known. The current study does
not directly address whether controlled cooling is effective
against acne but strongly suggests that acne treatment with
modern controlled cooling devices is worth investigating. To
explore this, we plan to conduct prospective, controlled
clinical trials in acne patients in the near future.
MATERIALS AND METHODS
Murine experiments
Adult female C57BL/6J mice were purchased from Jackson Lab (Bar
Harbor, ME). All animal procedures were performed in compliance
with the Public Health Service Policy on Humane Care and Use of
Laboratory Animals and approved by the Massachusetts General
Hospital Institutional Animal Care and Use Committee. After
anesthesia (ketamine/xylazine, 90/9 mg kg−1 intraperitoneal), the
animal’s ear was placed in contact with a computer-controlled
cooling plate and held in place with a foam block and a 100-gram
weight (Supplementary Figure S1 online). The contralateral ear was
left untreated for control. Various target temperatures, duration, rates
of cooling and re-warming were tested, as shown in Table 1. Each set
of experimental conditions was repeated independently on at least
three animals.
Histological processing and analysis
Animals were euthanized at various post-cooling time points, and the
ears were harvested, ﬁxed in 4% formaldehyde, embedded in
parafﬁn, sectioned in 5-μm thickness, and stained with hematoxylin
and eosin for histologic analysis. The number of sebaceous glands
with and without histological evidence for damage was assessed
blindly in treated and control ears, in three independent experiments
at 72 hours and 1 week after cooling. A gland was considered
damaged when histologic signs of cellular damage—eosinophilic
precipitate, pyknotic nuclei, and retraction of cytoplasmic contents
from gland lumen—were observed in three or more sebocytes (out of
an average of ﬁve cells per gland). Four step sections 100 microns
apart from each ear were quantiﬁed. Hematoxylin and eosin–stained
tissue sections were imaged using a slide scanner (NanoZoomer,
Hamamatsu Photonics, Hamamatsu, Japan). The total number of
sebaceous glands in each tissue section was counted by a blinded
observer and normalized by the surface length of the corresponding
section, and the cross-sectional area of individual sebaceous glands
in each section was measured using NDPViewer software (Hama-
matsu Photonics). Over 100 glands per sample were evaluated for
quantitative analysis. Speciﬁc staining for PI, ALP, lipids, and
immunohistochemical markers was performed following previously
established protocols (Handjiski et al., 1994; Uemura et al., 2002;
Martinez-Corral et al., 2012), as described in detail in the
Supplementary Materials and Methods online.
Clinical trial
This prospective, site randomized trial was approved by the
Institutional Review Board of the Massachusetts General Hospital
and registered at clinicaltrials.gov (NCT01686841).
Protocol
Eleven male volunteers between the ages of 18–25 with healthy skin
and measurable sebum production (420 on the Sebumeter) were
recruited for the study, and written informed consent was obtained.
Subjects with a history of vitiligo, keloid formation, and cold sensitive
disorders were excluded. Two 5×5.7 cm rectangles were marked on
either side of the scapula and designated as the treatment sites.
Assignment
Subjects were randomized to one of the two treatment temperatures
(−10 and − 15 °C). Treatment areas on either side of the spine were
randomized to receive one 20-minute cycle or two 10-minute cycles
with re-warming up to 10 °C surface temperature in between. A site
on the lateral scapula was chosen as an untreated control. The
treatment sites were marked with surgical markers and photographed
before and immediately after treatment, as well as in each subsequent
post-treatment time point (Supplementary Figure S4 online).
Participant ﬂow and follow-up
Each subject was evaluated before, immediately after, and at
72 hours, 1, 2, and 4 weeks after treatment. At each evaluation,
the treatment sites were photographed, and sebum production was
measured using a Sebumeter (Courage+Khazaka electronic GmbH,
Cologne, Germany)—the test sites were cleaned with 70% alcohol
until sebum levels were no longer detectable, followed by a 2-hour
incubation period during which the subjects remained in a
temperature- and humidity-controlled room, then sebum output
was measured following the manufacturer’s instructions. To mini-
mize confounding effects caused by diurnal variations in sebum
output, sebum output for each subject was always measured at the
same time of day on each visit, ± 2 hours. The subjects were also
questioned regarding symptoms that occurred at the treatment sites.
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3mm punch biopsies were collected 72 hours after treatment, with
local anesthesia (1% lidocaine with epinephrine), and processed for
histology as described above. Biopsy sites were separated from sites
used for sequential sebum output measurements to minimize the
potential inﬂuence of a skin biopsy on local sebum output.
Analysis
For sebum output measurements in the clinical trial, a mixed-model
repeated-measures analysis of variance was used in order to account
for the two treatment temperatures and the two different treatment
durations with longitudinal assessments at 72 hours and 2 weeks. The
three sebum measurements for each site per subject were incorporate
as replicates in the model. Two-sided Po0.05 was considered
statistically signiﬁcant with Bonferroni adjustment as appropriate to
minimize Type I errors due to multiple comparison. Statistical
analysis was performed using IBM SPSS Statistics (version 21.0, IBM,
Armonk, NY). P-values o0.05 were considered statistically
signiﬁcant.
Statistical analysis
In the murine model, repeated measures analysis of variance was
applied to account for multiple measurements per animal in
comparing absolute gland number and percentage damaged glands
at 72 hours and 1 week compared with control with the Wald test
used to test for differences. In addition, a multivariate logistic
regression analysis was utilized to evaluate the effects of temperature,
rate, duration, and cycles of cooling on selective damage of
sebaceous glands as a binary outcome.
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